Millions of healthcare workers are exposed to chemotherapy and other hazardous drugs annually. Studies have shown that exposure to these hazardous drugs can cause serious health problems, “such as cancer, reproductive and development problems… and other adverse effects that can be irreversible even after low-level exposures,” according to the Occupational Safety & Health Administration (OSHA), National Institute of Occupational Safety & Health (NIOSH), and Joint Commission.1, 2, 3
"In fact, published studies have shown that workplace exposures to hazardous drugs can cause both acute and chronic health effects such as skin rashes, adverse reproductive outcomes (including infertility, spontaneous abortions, and congenital malformations), and possibly leukemia and other cancers. The health risk depends on how much exposure a worker has to these drugs and how toxic they are." 3
Many institutions have adopted Closed System Transfer Devices to protect workers from exposure to chemotherapy and other hazardous drugs, but today’s CSTDs are not complete solutions. It’s time for a smarter Closed System Transfer Device solution designed to solve these issues – discover Halo.
1 NIOSH Alert: Preventing occupational exposure to antineoplastic and other hazardous drugs in health care settings. http://www.cdc.gov/niosh/docs/2004-165/ Publication No. 2004-165. Washington DC: NIOSH; 2004.
2 OSHA, NIOSH and Joint Commission Joint Statement on Safe Handling of Hazardous Drugs. https://www.osha.gov/ooc/drug-letter.pdf Issued April 4, 2011.
3 Hazardous Drug Exposures in Health Care. Centers for Disease Control and Prevention Web site. http://www.cdc.gov/niosh/topics/hazdrug/ Updated May 15, 2015.
This post is related to:IV/Infusion Resources/USP <797> Resources